- Home
- PI vs LNTH Comparison
PI vs LNTH Comparison
Compare PI & LNTH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PI
- LNTH
- Stock Information
- Founded
- PI 2000
- LNTH 1956
- Country
- PI United States
- LNTH United States
- Employees
- PI N/A
- LNTH N/A
- Industry
- PI Industrial Machinery/Components
- LNTH Biotechnology: In Vitro & In Vivo Diagnostic Substances
- Sector
- PI Technology
- LNTH Health Care
- Exchange
- PI Nasdaq
- LNTH Nasdaq
- Market Cap
- PI 3.2B
- LNTH 3.6B
- IPO Year
- PI 2016
- LNTH 2015
- Fundamental
- Price
- PI $161.91
- LNTH $54.05
- Analyst Decision
- PI Buy
- LNTH Strong Buy
- Analyst Count
- PI 6
- LNTH 6
- Target Price
- PI $148.67
- LNTH $105.50
- AVG Volume (30 Days)
- PI 625.4K
- LNTH 2.0M
- Earning Date
- PI 07-30-2025
- LNTH 08-06-2025
- Dividend Yield
- PI N/A
- LNTH N/A
- EPS Growth
- PI N/A
- LNTH N/A
- EPS
- PI N/A
- LNTH 3.77
- Revenue
- PI $358,938,000.00
- LNTH $1,520,653,000.00
- Revenue This Year
- PI N/A
- LNTH $4.57
- Revenue Next Year
- PI $25.13
- LNTH $9.41
- P/E Ratio
- PI N/A
- LNTH $14.37
- Revenue Growth
- PI 13.96
- LNTH 5.75
- 52 Week Low
- PI $60.85
- LNTH $47.25
- 52 Week High
- PI $239.88
- LNTH $118.21
- Technical
- Relative Strength Index (RSI)
- PI 66.98
- LNTH 29.17
- Support Level
- PI $150.87
- LNTH $51.40
- Resistance Level
- PI $170.36
- LNTH $57.21
- Average True Range (ATR)
- PI 8.58
- LNTH 2.21
- MACD
- PI 1.22
- LNTH -1.03
- Stochastic Oscillator
- PI 84.10
- LNTH 27.75
About PI Impinj Inc.
Impinj Inc operates a platform that enables wireless connectivity to everyday items by delivering each item's identity, location, and authenticity to business and consumer applications. Its platform includes endpoint integrated circuits (ICs) product, a miniature radios-on-a-chip, which attach to and identify their host items; and connectivity layer that comprises readers, gateways, and reader ICs to wirelessly identify, locate, authenticate, and engage endpoints via RAIN, as well as provide power to and communicate bidirectionally with endpoint ICs. Geographically, the company has a business presence in the Americas, Asia Pacific, Europe, Middle East and Africa, of which key revenue is derived from the operations in the Asia Pacific region.
About LNTH Lantheus Holdings Inc.
Lantheus Holdings Inc caters to the United States healthcare sector with the development of diagnostic products. Its products are in three categories: Precision Diagnostics, Radiopharmaceutical Oncology, and Strategic Partnerships and Other Revenue. Precision Diagnostic products assist healthcare professionals Find and Follow diseases, with a focus in cardiology. Radiopharmaceutical Oncology diagnostics and therapeutics help HCPs Find, Fight and Follow cancer. Strategic Partnerships focus on enabling precision medicine through the use of biomarkers, digital solutions and pharma services platforms, and also includes license of RELISTOR to Bausch Health Companies, Inc.